Tag: genomics
-
Precision Cancer Genomics Company Adds $23M in Early Funds
Biofidelity says its process simplifies detection of genetic indicators in tumors enabling more precise therapies for cancer patients.
-
Clinical Trial Underway for One-Time Crispr HIV Treatment
A clinical trial is underway assessing a therapy for HIV infections that aims to eradicate the virus with one dose of the gene-editing technique Crispr.
-
NIH Begins Large-Scale Precision Nutrition Study
National Institutes of Health awarded new funds for academic and industry labs to develop algorithms for predicting individual responses to food and nutrition.
-
Genetics Help Control Dangerous Insects
Advances in genetics are providing communities, businesses, and homeowners with new tools for controlling harmful insects.
-
Biotech, AI Company Partner on Covid-19 Alert System
A developer of Covid-19 vaccines and an artificial intelligence company are building a system to quickly detect dangerous SARS-CoV-2 variants.
-
Biotech Partners on Gene Editing Tech in $1.35B Deal
A biotechnology company is making its precise gene editing technology available to drug maker Pfizer for rare diseases, in a deal valued at $1.35 billion.
-
Sanofi Partners in $5.3B Precision Drug Discovery Deal
A company using artificial intelligence to design drugs for personalized treatments is partnering with drug maker Sanofi in a deal valued at $5.3 billion.
-
Optogenetics Start-Up Raises $6M for Retinal Therapy
A new company developing a therapy using light-sensitive proteins for treating an inherited eye disorder is raising $6 million in seed funds.
-
FDA Clears Rapid At-Home Covid-19 Test
The Food and Drug Administration granted an emergency authorization to a quick diagnostic test for SARS-CoV-2 viruses, conducted at home.
-
Foundation Backing Expanded Pandemic Surveillance
A population genomics company is receiving foundation support for expanding its detailed surveillance of respiratory disease outbreaks in the U.S.